155 related articles for article (PubMed ID: 38638686)
1. Chemoinformatics and machine learning techniques to identify novel inhibitors of the lemur tyrosine kinase-3 receptor involved in breast cancer.
Alrumaihi F
Front Mol Biosci; 2024; 11():1366763. PubMed ID: 38638686
[TBL] [Abstract][Full Text] [Related]
2. Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach.
Anbarasu K; Jayanthi S
3 Biotech; 2018 May; 8(5):228. PubMed ID: 29719770
[TBL] [Abstract][Full Text] [Related]
3. Designing and optimization of novel human LMTK3 inhibitors against breast cancer - a computational approach.
Anbarasu K; Jayanthi S
J Recept Signal Transduct Res; 2017 Feb; 37(1):51-59. PubMed ID: 27056562
[TBL] [Abstract][Full Text] [Related]
4. Structural modeling and molecular dynamics studies on the human LMTK3 domain and the mechanism of ATP binding.
Anbarasu K; Jayanthi S
Mol Biosyst; 2014 May; 10(5):1139-45. PubMed ID: 24619340
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Virtual Screening of High-Affinity ATP-Competitive Inhibitors Against Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: A Novel Therapeutic Target for Breast Cancer.
Sarma H; Mattaparthi VSK
Interdiscip Sci; 2019 Sep; 11(3):527-541. PubMed ID: 30066129
[TBL] [Abstract][Full Text] [Related]
6. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of lemur tyrosine kinase 3 in postoperative gastric cancer.
Li Z; Wu J; Ji M; Shi L; Xu B; Jiang J; Wu C
Mol Clin Oncol; 2014 Sep; 2(5):756-760. PubMed ID: 25054042
[TBL] [Abstract][Full Text] [Related]
8. Discovery of cyclic guanidine-linked sulfonamides as inhibitors of LMTK3 kinase.
Ortiz MA; Michaels H; Molina B; Toenjes S; Davis J; Marconi GD; Hecht D; Gustafson JL; Piedrafita FJ; Nefzi A
Bioorg Med Chem Lett; 2020 May; 30(9):127108. PubMed ID: 32192797
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Cairns J; Ingle JN; Kalari KR; Shepherd LE; Kubo M; Goetz MP; Weinshilboum RM; Wang L
Breast Cancer Res; 2019 Apr; 21(1):47. PubMed ID: 30944027
[TBL] [Abstract][Full Text] [Related]
10. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.
Giamas G; Filipović A; Jacob J; Messier W; Zhang H; Yang D; Zhang W; Shifa BA; Photiou A; Tralau-Stewart C; Castellano L; Green AR; Coombes RC; Ellis IO; Ali S; Lenz HJ; Stebbing J
Nat Med; 2011 Jun; 17(6):715-9. PubMed ID: 21602804
[TBL] [Abstract][Full Text] [Related]
11. LMTK3 confers chemo-resistance in breast cancer.
Stebbing J; Shah K; Lit LC; Gagliano T; Ditsiou A; Wang T; Wendler F; Simon T; Szabó KS; O'Hanlon T; Dean M; Roslani AC; Cheah SH; Lee SC; Giamas G
Oncogene; 2018 Jun; 37(23):3113-3130. PubMed ID: 29540829
[TBL] [Abstract][Full Text] [Related]
12. The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.
Agnarelli A; Lauer Betrán A; Papakyriakou A; Vella V; Samuels M; Papanastasopoulos P; Giamas C; Mancini EJ; Stebbing J; Spencer J; Cilibrasi C; Ditsiou A; Giamas G
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614307
[TBL] [Abstract][Full Text] [Related]
13. Structural Dynamics of P-Rex1 Complexed with Natural Leads Establishes the Protein as an Attractive Target for Therapeutics to Suppress Cancer Metastasis.
Hameed AR; Ali SF; Alsallameh SMS; Muhseen ZT; Almansour NM; ALSuhaymi N; Alsugoor MH; Allemailem KS
Biomed Res Int; 2023; 2023():3882081. PubMed ID: 38098889
[TBL] [Abstract][Full Text] [Related]
14. The multifaceted role of lemur tyrosine kinase 3 in health and disease.
Ditsiou A; Gagliano T; Samuels M; Vella V; Tolias C; Giamas G
Open Biol; 2021 Sep; 11(9):210218. PubMed ID: 34582708
[TBL] [Abstract][Full Text] [Related]
15. The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.
Xu Y; Zhang H; Lit LC; Grothey A; Athanasiadou M; Kiritsi M; Lombardo Y; Frampton AE; Green AR; Ellis IO; Ali S; Lenz HJ; Thanou M; Stebbing J; Giamas G
Sci Signal; 2014 Jun; 7(330):ra58. PubMed ID: 24939894
[TBL] [Abstract][Full Text] [Related]
16. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
Jiang T; Lu X; Yang F; Wang M; Yang H; Xing N
FEBS Open Bio; 2020 Oct; 10(10):2107-2121. PubMed ID: 32865871
[TBL] [Abstract][Full Text] [Related]
17. The structure-function relationship of oncogenic LMTK3.
Ditsiou A; Cilibrasi C; Simigdala N; Papakyriakou A; Milton-Harris L; Vella V; Nettleship JE; Lo JH; Soni S; Smbatyan G; Ntavelou P; Gagliano T; Iachini MC; Khurshid S; Simon T; Zhou L; Hassell-Hart S; Carter P; Pearl LH; Owen RL; Owens RJ; Roe SM; Chayen NE; Lenz HJ; Spencer J; Prodromou C; Klinakis A; Stebbing J; Giamas G
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33188023
[TBL] [Abstract][Full Text] [Related]
18. LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.
Klug LR; Bannon AE; Javidi-Sharifi N; Town A; Fleming WH; VanSlyke JK; Musil LS; Fletcher JA; Tyner JW; Heinrich MC
Oncogene; 2019 Feb; 38(8):1200-1210. PubMed ID: 30242244
[TBL] [Abstract][Full Text] [Related]
19. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
20. LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.
Stebbing J; Filipovic A; Ellis IO; Green AR; D'Silva TR; Lenz HJ; Coombes RC; Wang T; Lee SC; Giamas G
Breast Cancer Res Treat; 2012 Apr; 132(2):537-44. PubMed ID: 21671015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
